Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
26 May 2020 → 25 May 2023
3.2 Clinical medicine, Expert, Latvian Council of Science
18 Mar 2017 → 16 Mar 2020
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Inga Stuķēna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Projects
- 1 Finished
-
Benefits of an arterial hypertension therapy evaluation model combining laboratory and clinical capabilities in polypharmacy conditions
Stuķēna, I. (Project leader), Trušinskis, K. (Expert) & Urtāne, I. (Expert)
1/04/22 → 31/03/23
Project: RSU grants
-
PAI-1 level differences in malignant plural effusion, parapneumonic pleuritis, and cardiac hydrothorax
Zentina, D., Stukena, I., Krams, A. & Lejnieks, A., Sept 2019, In: Medicina (Lithuania). 55, 9, 567.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)8 Downloads (Pure) -
Cognitive function in a randomized trial of evolocumab
EBBINGHAUS Investigators, Giugliano, R. P. & Stuķēna, I. (Member of the Working Group), 17 Aug 2017, In: New England Journal of Medicine. 377, 7, p. 633-643 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile256 Citations (Scopus)11 Downloads (Pure) -
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
APEX Investigators & Stukena, I. (Member of the Working Group), 1 Jul 2017, In: Journal of the American Heart Association. 6, 7, e006015.Research output: Contribution to journal › Article › peer-review
Open AccessFile35 Citations (Scopus)39 Downloads (Pure) -
Evolocumab and clinical outcomes in patients with cardiovascular disease
FOURIER Steering Committee and Investigators & Stukena, I. (Member of the Working Group), 4 May 2017, In: New England Journal of Medicine. 376, 18, p. 1713-1722 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4208 Citations (Scopus) -
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
APEX Investigators & Stukena, I. (Member of the Working Group), 14 Feb 2017, In: Circulation. 135, 7, p. 648-655Research output: Contribution to journal › Article › peer-review
Open AccessFile59 Citations (Scopus)340 Downloads (Pure)
Activities
-
22nd European Congress of Internal Medicine (Event)
Stuķēna, I. (Reviewer of conference paper)
Dec 2023Activity: Publication peer-review and editorial work types › Publication Peer-review
-
9th RSU International Student Conference 2023
Stuķēna, I. (Jury committee member)
27 Mar 2023 → 28 Mar 2023Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Latvian Internists' Society (External organisation)
Stuķēna, I. (President)
2023 → 2027Activity: Membership types › Membership of NGOs
-
9th RSU International Student Conference 2023 (Event)
Stuķēna, I. (Reviewer of conference paper)
2023Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Council of the Faculty of Pharmacy of the Rīga Stradiņš University (Organisational unit)
Stuķēna, I. (Member)
11 Nov 2020 → 10 Nov 2025Activity: Membership types › Membership of council